Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis

Blood. 2003 May 1;101(9):3749. doi: 10.1182/blood-2003-01-0135.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Adolescent
  • Adult
  • Anemia / chemically induced
  • Cohort Studies
  • Follow-Up Studies
  • Hemorrhage / chemically induced
  • Humans
  • Hydroxyurea / adverse effects
  • Hydroxyurea / therapeutic use*
  • Incidence
  • Middle Aged
  • Quinazolines / adverse effects
  • Quinazolines / therapeutic use
  • Risk
  • Thrombocythemia, Essential / complications
  • Thrombocythemia, Essential / drug therapy*
  • Thrombophilia / drug therapy
  • Thrombophilia / etiology*
  • Thrombosis / epidemiology*
  • Thrombosis / prevention & control

Substances

  • Quinazolines
  • anagrelide
  • Hydroxyurea